查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1679428

美國乳房重建市場規模、佔有率、趨勢分析報告：按產品、類型、最終用途和細分市場預測，2025-2030 年

U.S. Breast Reconstruction Market Size, Share & Trends Analysis Report By Product (Implants, Tissue Expander, Acellular Dermal Matrix), By Shape (Round, Anatomical), By End-use, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

美國乳房重建市場的成長和趨勢

根據 Grand View Research, Inc. 的新報告，美國乳房重建市場預計到 2030 年將達到 16.5 億美元，2025 年至 2030 年的複合年成長率為 6.8%。

由於尋求重組的乳癌倖存者數量不斷增加、人們對乳癌治療的認知不斷提高以及手術技術的進步，市場正在經歷強勁成長。此外，重組手術的保險覆蓋範圍的擴大和微創技術的採用率的提高也促進了市場的成長。隨著越來越多的女性接受切除術並尋求恢復乳房外觀的方法，對這些手術的需求只會增加。

美國乳房重建市場的新產品發布和 FDA核准透過刺激創新、提高安全標準和改善臨床結果推動了乳房重建的重要進步。 2023 年 10 月，Establishment Labs 推出了 Motiva Flora SmoothSilk 組織擴張器，這是美國首個獲得 FDA 批准的產品。這使得 MRI 掃描能夠不受阻礙地進行，這對於術後監測和癌症篩檢至關重要。 Establishment Labs 的這項創新有可能簡化需要 MRI 掃描的患者的乳房重建過程。

隨著患者越來越青睞這項技術，美國乳房重建市場正向組織擴張器發生重大轉變。組織擴張器，也稱為組織擴張器系統，是一種可植入裝置，用於拉伸和擴張皮膚和軟組織，為乳房重建手術做準備。該技術因其能夠提供更自然的外觀和感覺，並減少恢復時間和疤痕而廣受歡迎。乳房切除術後，使用組織擴張器來擴大乳房袋，以便放置乳房植入。兩階段擴張器至植入乳房重建占美國乳房重建手術的一半以上。在過去的幾十年裡，組織擴張技術取得了顯著的進展。

美國乳房重建市場報告重點

  • 根據產品來看，與組織瓣等其他選擇相比，植入由於外觀自然、恢復時間更短、風險更低，佔據了市場主導地位，擁有最大的收入佔有率。
  • 根據形態，圓形部分佔據了最大的銷售佔有率，因為它提供了許多患者喜歡的更飽滿、更對稱的外觀。
  • 根據最終用途，醫院佔收入的最大佔有率。該醫院進行最多的乳房切除術和重組手術。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章美國乳房重建市場變數、趨勢與範圍

  • 市場體系展望
    • 補貼市場前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 美國乳房重建市場分析工具
    • 產業分析—波特五力分析
    • PESTEL分析

第4章美國乳房重建市場：按產品分類的估計和趨勢分析

  • 細分儀表板
  • 美國乳房重建市場的產品趨勢分析
  • 2018-2030年美國乳房重建市場規模及產品趨勢分析
  • 植入
    • 矽膠乳房植入
    • 生理食鹽水乳房植入
  • 組織擴張器
    • 生理食鹽水擴張器
    • 空氣組織擴張器
  • 去細胞真皮基質

第5章美國乳房重建市場：按類型、估計和趨勢分析

  • 細分儀表板
  • 美國乳房重建市場的波動
  • 2018-2030年美國乳房重建市場規模及趨勢分析（按類型）
  • 圓形的
  • 解剖學

第6章美國乳房重建市場：按最終用途的估計和趨勢分析

  • 細分儀表板
  • 美國乳房重建市場的最終用途趨勢分析
  • 2018-2030年美國乳房重建市場規模及趨勢分析（依最終用途）
  • 醫院
  • 美容診所
  • 門診手術中心

第7章競爭格局

  • 市場參與企業分類
  • 主要企業簡介
    • Mentor Medical Systems（Johnson & Johnson）
    • Allergan, Inc.（AbbVie）
    • Sientra, Inc.（Acquired by Tiger Aesthetics Medical, LLC）
    • Ideal Implant, Inc.（Bimini Health Tech.）
    • Establishment Labs
    • RTI Surgical
    • Integra LifeSciences Corporation
Product Code: GVR-4-68040-523-4

U.S. Breast Reconstruction Market Growth & Trends:

The U.S. breast reconstruction market size is anticipated to reach USD 1.65 billion by 2030 and is projected to expand at a CAGR of 6.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is experiencing significant growth due to the increasing number of breast cancer survivors seeking reconstruction, growing awareness about breast cancer treatments, and advancements in surgical techniques. In addition, the availability of insurance coverage for reconstruction procedures and the increasing adoption of minimally invasive methods contribute to market growth. As more women undergo mastectomies and look for options to restore breast appearance, the demand for these procedures continues to rise.

New product launches and FDA approvals in the U.S. breast reconstruction market drive significant breast reconstruction advancements by promoting innovation, enhancing safety standards, and improving clinical outcomes. In October 2023, Establishment Labs announced the FDA clearance of their Motiva Flora SmoothSilk Tissue Expander, the first of its kind to receive FDA clearance in the U.S. The Motiva Flora expander eliminates the use of magnets in the filling port, making it MRI-conditional. It allows unimpeded MRI scans, crucial for post-surgical monitoring and cancer screening. This innovation by Establishment Labs has the potential to streamline the breast reconstruction process for patients who require MRI scans.

The U.S. breast reconstruction market is witnessing a significant shift toward tissue expanders as patients increasingly prefer this technology. Tissue expanders, also known as tissue expander systems, are implantable devices used to stretch and expand the skin & soft tissues in preparation for breast reconstruction surgery. This technology has gained popularity due to its ability to provide a more natural look and feel, as well as reduced recovery time & scarring. Tissue expanders are used to extend the breast pocket following a mastectomy so that a breast implant can be placed. Two-stage expander-to-implant breast reconstruction accounts for more than half of all breast reconstruction surgeries in the U.S. In the last few decades, tissue expansion technology has significantly advanced.

U.S. Breast Reconstruction Market Report Highlights:

  • Based on product, the implants segment dominates the market with the largest revenue share owing to their ability to provide natural-looking results, shorter recovery times, and lower risk compared to other options like tissue flaps.
  • Based on shape, the round segment dominate the market with the largest revenue share because they offer a fuller, more symmetrical appearance, which many patients prefer.
  • Based on end use, the hospitals dominated the market with the largest revenue share. Hospitals perform the highest number of mastectomy and reconstruction surgeries.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Breast Reconstruction Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing awareness and acceptability of breast reconstruction among women with breast cancer
      • 3.2.1.2. Increasing number of breast reconstructive procedures
      • 3.2.1.3. Technological advancements
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Complications associated with implants and product recalls
  • 3.3. U.S. Breast Reconstruction Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. U.S. Breast Reconstruction Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Breast Reconstruction Market Product Movement Analysis
  • 4.3. U.S. Breast Reconstruction Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Implants
    • 4.4.1. Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Silicone Breasts Implants
      • 4.4.2.1. Silicone Breasts Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Saline Breasts Implants
      • 4.4.3.1. Saline Breasts Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Tissue Expander
    • 4.5.1. Tissue Expander Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Saline Expander
      • 4.5.2.1. Saline Expander Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Air Tissue Expander
      • 4.5.3.1. Air Tissue Expander Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Acellular Dermal Matrix
    • 4.6.1. Acellular Dermal Matrix Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Breast Reconstruction Market: Shape Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Breast Reconstruction Market Shape Movement Analysis
  • 5.3. U.S. Breast Reconstruction Market Size & Trend Analysis, by Shape, 2018 to 2030 (USD Million)
  • 5.4. Round
    • 5.4.1. Round Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Anatomical
    • 5.5.1. Anatomical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Breast Reconstruction Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Breast Reconstruction Market End Use Movement Analysis
  • 6.3. U.S. Breast Reconstruction Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Cosmetology Clinics
    • 6.5.1. Cosmetology Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Ambulatory Surgery Centers
    • 6.6.1. Ambulatory Surgery Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
  • 7.2. Key Company Profiles
    • 7.2.1. Mentor Medical Systems (Johnson & Johnson)
      • 7.2.1.1. Company Overview
      • 7.2.1.2. Financial Performance
      • 7.2.1.3. Service Benchmarking
      • 7.2.1.4. Strategic Initiatives
    • 7.2.2. Allergan, Inc. (AbbVie)
      • 7.2.2.1. Company Overview
      • 7.2.2.2. Financial Performance
      • 7.2.2.3. Service Benchmarking
      • 7.2.2.4. Strategic Initiatives
    • 7.2.3. Sientra, Inc. (Acquired by Tiger Aesthetics Medical, LLC)
      • 7.2.3.1. Company Overview
      • 7.2.3.2. Financial Performance
      • 7.2.3.3. Service Benchmarking
      • 7.2.3.4. Strategic Initiatives
    • 7.2.4. Ideal Implant, Inc. (Bimini Health Tech.)
      • 7.2.4.1. Company Overview
      • 7.2.4.2. Financial Performance
      • 7.2.4.3. Service Benchmarking
      • 7.2.4.4. Strategic Initiatives
    • 7.2.5. Establishment Labs
      • 7.2.5.1. Company Overview
      • 7.2.5.2. Financial Performance
      • 7.2.5.3. Service Benchmarking
      • 7.2.5.4. Strategic Initiatives
    • 7.2.6. RTI Surgical
      • 7.2.6.1. Company Overview
      • 7.2.6.2. Financial Performance
      • 7.2.6.3. Service Benchmarking
      • 7.2.6.4. Strategic Initiatives
    • 7.2.7. Integra LifeSciences Corporation
      • 7.2.7.1. Company Overview
      • 7.2.7.2. Financial Performance
      • 7.2.7.3. Service Benchmarking
      • 7.2.7.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 U.S Breast Reconstruction Market, By Product, 2018 - 2030 (USD Million)
  • Table 4 U.S Breast Reconstruction Market, By Shape, 2018 - 2030 (USD Million)
  • Table 5 U.S Breast Reconstruction Market, By End Use, 2018 - 2030 (USD Million)
  • Table 6 Participant's Overview
  • Table 7 Financial Performance
  • Table 8 Product Benchmarking
  • Table 9 Strategic Initiatives

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 U.S. Breast Reconstruction Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 U.S. Breast Reconstruction Market, for Implants, 2018 - 2030 (USD Million)
  • Fig. 15 U.S. Breast Reconstruction Market, for Silicone Breasts Implants, 2018 - 2030 (USD Million)
  • Fig. 16 U.S. Breast Reconstruction Market, for Saline Breasts Implants, 2018 - 2030 (USD Million)
  • Fig. 17 U.S. Breast Reconstruction Market, for Tissue Expander, 2018 - 2030 (USD Million)
  • Fig. 18 U.S. Breast Reconstruction Market, for Saline Expander, 2018 - 2030 (USD Million)
  • Fig. 19 U.S. Breast Reconstruction Market, for Air Tissue Expander, 2018 - 2030 (USD Million)
  • Fig. 20 U.S. Breast Reconstruction Market, for Acellular Dermal Matrix, 2018 - 2030 (USD Million)
  • Fig. 21 U.S. Breast Reconstruction Market, for Round, 2018 - 2030 (USD Million)
  • Fig. 22 U.S. Breast Reconstruction Market, for Anatomical, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. Breast Reconstruction Market, for Hospitals, 2018 - 2030 (USD Million)
  • Fig. 24 U.S. Breast Reconstruction Market, for Cosmetology Clinics, 2018 - 2030 (USD Million)
  • Fig. 25 U.S. Breast Reconstruction Market, for Ambulatory Surgical Centers, 2018 - 2030 (USD Million)